Download presentation
Presentation is loading. Please wait.
Published byひでき はらしない Modified over 6 years ago
1
Randomized trial of a dry-powder, fibrin sealant in vascular procedures
NavYash Gupta, MD, FACS, Ian Chetter, MD, PhD, Paul Hayes, MD, Albert H. O.-Yurvati, DO, Gregory L. Moneta, MD, Surendra Shenoy, MD, John P. Pribble, PharmD, Linda A. Zuckerman, PhD Journal of Vascular Surgery Volume 62, Issue 5, Pages (November 2015) DOI: /j.jvs Copyright © 2015 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Patient disposition. TBS, Target bleeding site.
Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Time to hemostasis (TTH). Kaplan-Meier analyses of TTH are presented for all vascular patients and by concomitant medication subgroup: antiplatelet agents only, anticoagulants only, and antiplatelet agents and anticoagulants; P < .05 for comparison between treatment arms in each population, log-rank test. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.